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Abstract 
Background: Chronic back pain is known to be associated with altered tactile acuity. Tactile acuity is measured using 
the Two‑Point Discrimination (TPD) test in both clinical and research settings. In subjects with chronic low back pain, 
the TPD threshold (TPDT) is increased and is associated with persistent pain. It remains unknown, however, whether 
TPDT is also altered in cases of clinical acute pain, or whether it could be used as a predictor of future pain and dis‑
ability at an early stage of LBP.
The main objective of this study was to investigate the predictive value of baseline TPDT for pain and disability at 3 
and 6 months after the onset of acute LBP. The TPDT in acute low back pain (LBP) and the development of TPDT over 
6 months has also been assessed.
Methods: LBP participants (n = 124) with acute LBP (< 4 weeks) were included. Subjects were examined within 
4 weeks of pain onset and followed‑up after 3 and 6 months of pain onset. Horizontal and vertical TPDTs of the lower 
back were collected. Linear mixed models were subsequently used to evaluate the association of TPDT with pain and 
disability over time.
Results: The vertical TPDT showed a mean (SD) of 4.9 cm (1.6) and the horizontal TPDT a mean (SD) of 6.0 cm (1.5) at 
baseline. The vertical TPDT altered from baseline up to 6 months from 4.9 to 4.6 cm and the horizontal TPDT from 6.0 
to 5.4 cm. The association between the TPDT and the Oswestry Disability Index (ODI) after 6 months was moderate. 
Linear mixed models revealed no association between TPDT, pain and disability over the progression of LBP.
Conclusion: TPDTs appear to be raised in subjects with acute LBP. However, our study revealed no predictive capabil‑
ity of the TPDT for disability and pain. No comparisons are possible in the absence of similar studies, indicating the 
need for further research is in this area.
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Background
With a lifetime prevalence of up to 85% [1], low back pain 
(LBP) is the most common symptom of all musculoskel-
etal disorders [2]. Within the first 2 months of the onset 
of pain, most subjects show substantial improvements in 
pain and disability [2]. However, within 1 year after recov-
ery from an acute episode of LBP, 69% of subjects suffer 
recurrent LBP [3]. On average, about 3–10% of individu-
als develop persistent pain after an acute episode of LBP. 
In addition, these individuals do not return to work after-
wards [4]. This transition from acute LBP to chronic LBP 
(CLBP) is not linear [4]. In general, CLBP was defined as 
persistent or recurrent pain lasting longer than 3 months 
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and is associated with emotional stress and/or significant 
functional disability [5]. Besides, 15% of subjects diag-
nosed with CLBP show no improvement after 2 years [6]. 
CLBP can lead to substantial health-related costs and is 
responsible for an increasing socio-economic burden [7, 
8]. Dynamic maladaptive interactions between physi-
ological, psychological and social factors increase the 
likelihood of chronic pain and disability [9]. Pain inten-
sity, duration resp. frequency, and coping strategies are 
important predictors of chronic pain itself [10–12]. In 
addition, baseline values of depression and maladaptive 
cognitions are clinical predictors of pain intensity and 
disability after 6 months [13]. These results indicate the 
necessity to identify high-risk LBP subjects at the earliest 
possible stage [14, 15]. To date, besides psychosocial vari-
ables, few physical examinations have been shown to be 
predictive of pain persistence. To close this gap, we there-
fore propose tactile acuity as a novel prospective assess-
ment tool.
Tactile acuity
Tactile acuity is described as the perceived precision 
of touch [16] and has been found to be decreased in 
various chronic pain conditions [17]. Moreover, tac-
tile acuity is thought to represent a simple clinical 
measure of a cortical representation of tactile percep-
tion [18]. It can be measured by means of two-point 
discrimination (TPD). TPD is defined as the ability 
to perceive the smallest distance between two tac-
tile stimuli, placed at distinct points on the skin [19]. 
Tactile acuity is reduced in subjects with CLBP [20, 
21], resulting in higher TPDTs compared with healthy 
subjects [22]. Cross-sectional data have revealed no 
significant differences in TPDT between the affected 
and non-affected sites in unilateral CLBP [23]. In addi-
tion, vertical TPDTs are usually lower in comparison to 
horizontal TPDTs [20]. The extent to which the TPDT 
is affected in subjects at the acute stage of clinical LBP 
is still unknown. Similarly, the predictive value of the 
TPDT for the development of CLBP has not yet been 
investigated.
The main objective of this study is to investigate TPDTs 
in acute LBP and follow-up their longitudinal course over 
a 6-month period, with the aim to assess the predictive 
value of the TPDTs for pain and disability.
Methods
Study design
This project was part of a larger prospective longi-
tudinal cohort study. The overall study examines the 
setting, physical factors and psychological factors of 
LBP subjects, with a follow-up period of up to 1  year. 
In this repeated measure design study, subjects were 
investigated within the first 4 weeks of the onset of acute 
LBP (T1), at 3 months (T2), and finally at 6 months (T3). 
This part of the study focused on the measures of tactile 
acuity, pain and disability and the associations between 
them.
The study protocol is in accordance with the Declara-
tion of Helsinki and approval was obtained from the Ethics 
Committee of the Canton of Zurich (BASEC-No. 2016–
02,096). All experiments were performed in accordance 
with relevant guidelines and regulations.
Subjects
Subjects aged 18–65 years suffered from acute LBP. Inclu-
sion criteria required them to have been pain-free for a 
3-month period prior to the onset of the current episode. 
Access to the internet and a good knowledge of the Ger-
man language were further inclusion criteria. Excluded 
were persons who showed signs of serious pathologies, 
had given birth within the previous 12 months, were cur-
rently pregnant, had a history of severe psychiatric dis-
order, used psychiatric medications, or had progressive 
neurological symptoms.
Recruitment
Subjects were recruited in hospitals, private physiother-
apy practices and a university campus in the canton of 
Zurich (Switzerland). They were either contacted per-
sonally, via the university campus homepage, intranet, 
flyers, advertisements or per email. The selection criteria 
were reviewed prior to the first examination and signed 
informed consent was obtained.
Data collection
Various experienced physiotherapists carried out the 
clinical tests. To standardise the test procedures, the 
assessors received a manual with instructions for all 
tests and were trained in advance. Because the intra-
rater reliability of TPDT measurement has been shown 
to be high in healthy individuals, the measurements 
were performed by the same assessor whenever possi-
ble [24]. They were also blinded to the initial screening 
and to the results of the psychometric assessments of 
the subjects.
Measurements
For both TPDT measurements a horizontal line at the 
level of L3 was used as reference. The vertical TPDT was 
measured between Th12 and the S1 above the erector 
muscle on each side of the lumbar spine with the start-
ing point on the transversal line of L3.The horizontal 
TPDT was measured on the transversal line of L3 and 
with 5 cm between the tips of the plastic caliper and the 
lumbar spine in closed position. The stimulation intensity 
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was defined as ‘the slight touch of the skin on the back 
until the occurrence of the first blanching’ [24, 25]. TPDT 
was measured in 5  mm increments between 1–10  cm, 
one run ascending and one run descending. The proce-
dure was ended as soon as the subject stated that he felt 
two points in the ascending measurement and one point 
in the descending measurement. Subjects were invited 
to verbally express the number of perceived touches on 
the skin. Average values of the descending and ascend-
ing values were then calculated. In healthy adults, a mean 
TPDT value of 55.5 mm (12.5) has been determined [24], 
whereas TPDTs have been shown to be wider in subjects 
with CLBP [22].
Pain intensity was measured using the Numeric Rating 
Scale (NRS). The NRS is a single 11-point numeric scale 
ranging from 0 to 10, with 0 representing “no pain” and 
10 representing “worst pain you can imagine” [26].
Disability was assessed using the German version 
of the Oswestry Disability Index (ODI-D). The self-
administered questionnaire assesses functional sta-
tus, with substantive reliability (r = 0.96) and construct 
validity (r = 0.80) [27]. The Oswestry Disability Index 
(ODI) score is applied as follows: 0–20% = minimal dis-
ability; score ≤ 21- 40% = moderate disability; score ≤ 41- 
60% = severe disability; score ≤ 61–80% = crippling 
disability; ≤ 80–100% = bed-bound [28]. It has been 
found useful for monitoring subjects in clinical practice 
and as an outcome measure for clinical trials [27, 29].
The ODI questionnaire was completed by subjects 
online. It was required to be completed within 2 days of 
the date of request. The invitations were sent to subjects 
by email by the study director. If a respondent did not 
complete a questionnaire within the required time, an 
electronic reminder was sent. This was then followed by 
a telephone call if they had not responded to the request.
Data analysis
A subject was defined as a drop-out where there was: 
missing data in two subsequent measurements; an unreli-
able answer of more than one-week delay; or, withdrawal 
from the study. In our regression analysis, a list-wise 
deletion was performed to remove the series of values 
for which an observation was missing. Subsequently, the 
maximum likelihood was used to obtain estimates of the 
model parameters.
Descriptive statistics and a spearmen rank correlation 
analysis were initially applied to screen for dispropor-
tional subject characteristics, data outliers and absences 
of collinearity. Spearman rank correlations were catego-
rized using the interpretation table [30]. Following this, 
linear mixed regression models were fitted to the data to 
evaluate the effect of the independent variables on disa-
bility and pain over time. Age was included as a potential 
confounding variable based on its association with the 
TPDT [31]. Timepoints (T2 and T3) were entered as 
fixed effects and subjects as random effects (intercepts). 
The following equation describes the model:
with Yi,j representing ODI or pain intensity for subject i 
at time point j=T1, T2, T3.
β0 represents the intercept, I  the indicator function, 
β1,1 and β1,2 the time effect of time T2 and T2, respec-
tively, β2 the effect of TPDT, β3,1 and β3,2 the interaction 
effect at time T2 and T2, respectively, C the effect of 
the confounding factor (in this case, age), Ui the ran-
dom effect (in this case, subjects) ǫi,j the error term. The 
individual mean for the vertical and horizontal TPDT 
was calculated including the right and left side values. 
Four different models were fitted to the data: 1. Base-
line horizontal TPDT as predictor and pain intensity 
over time as dependent variable; 2. Baseline horizontal 
TPDT as predictor and ODI over time; 3. Baseline ver-
tical TPDT as predictor and pain intensity over time; 4. 
Baseline vertical TPDT as predictor and ODI over time.
The vertical and horizontal TPDTs were evaluated 
individually against the outcomes, since it is known that 
these measurements yield different values [20]. The effect 
on pain intensity and ODI was analysed based on the 
given clinically minimal important change [32]. All analy-
ses were performed using the R statistical software R ver-
sion 3.6.3 (2020–02-29).
Incomplete measurement data from patients who did 
not complete all 3 measurements were excluded from the 
evaluation of the linear mixed model.
Results
Characteristics of subjects
A total of 124 subjects were recruited in the period 
from November 2017 to December 2019. Of these sub-
jects, 21 dropped out for the following reasons: time 
constraints (6); health issues (pregnancy 2, back sur-
gery 1, spine fracture 1, no precise information (3)); 
personal reasons (1); respondent not adhering to speci-
fications (2); dissatisfaction with the scheduling (1); no 
information (1); no response to contact (3). On average, 
the subjects were 41 years old (SD 12.7) and 49 subjects 
were female (48%). Table  1 illustrates the characteris-
tics of the included subjects.
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TPDT in the acute pain state
At baseline, the mean TPDTs measured in this study 
were as follows: mean (SD) 4.9  cm (1.6) in the vertical 
direction and 6.0 cm (1.5) in the horizontal direction.
Time progression of the TPDT, ODI and pain intensity
The mean value of the vertical TPDT changed over 
6 months from T1: 4.9 cm to T2: 4.6 cm to T3: 4.6 cm. 
The horizontal TPDT mean value altered from T1: 6.0 cm 
to T2: 5.5 cm to T3: 5.4 cm. For disability, the mean ODI 
index decreased over 6 months from T1: 37 to T2: 29 to 
T3: 27. The pain intensity mean value decreased from T1: 
2.5 to T2: 1.16 to T3: 0.99 over 6 months. Figures 1, 2, 3 
and 4 illustrate the time progression of the variables with 
box plots. Table  2 shows in-depth information on the 
response variables ODI and pain intensity, as well as on 
the predictor TPDT.
Spearman rank correlation analysis showed fair cor-
relations between the vertical TPDTs, the ODI and pain 
intensity at T3. Weak correlations were observed at T1 
and weak negative correlations at T2. Fair correlations 
with the ODI were also found for the horizontal TPDTs 
at T2 and at T3. A weak correlation was observed at T1. 
In the case of horizontal TPDTs and pain intensity in 
T1 positive weak correlations were detected and T2-T3 
showed negative weak correlations. Large confidence 
intervals could be detected in almost all calculations. 
Table 3 shows the Spearman Rank correlations and confi-
dence intervals of TPDT and ODI/pain intensity.
Predictive value of baseline TPDT
Our analysis evaluated the interaction effects with time 
of baseline vertical and horizontal TPDTs on disability 
and pain over the 6-month measurement period. Base-
line TPDTs had no significant effects on either ODI or 
pain intensity (Tables  4, 5, 6 and 7). Furthermore, the 
ODI decreased over time, which was found in both 
the horizontal and vertical TPDT evaluations. Simi-
lar effects were found for pain intensity, which also 
decreased over time. The primary analysis showed no 
Table 1 Subject Characteristics at time point T1 (N = 124)
Pain intensity Numeric Rating Scale (NRS) 0–10, Disability Oswestry Disability 
Index (ODI): score ≤ 20% = minimal disability; score 21- 40% = moderate 
disability; score ≤ 41- 60% = severe disability; score > 61–80% = crippling 
disability; score > 81% bed-bound [28], TPDT Two-point discrimination threshold 




 Female 49 (47.6%)
 Male 51 (49.5%)
 No data 3 (2.9%)
Age (years)
 Range 21–65
 Mean (SD) 41 (12.7)
Pain Intensity
 Pain intensity (NRS, range = 0–10), mean (SD) 2.5 (2.1)
 NRS < 3 64%
 NRS > 3 34%
 No data 2%
Disability
 ODI (0–100%), mean (SD) 37 (11.2)
 Minimal disability 5%
 Moderate disability 62%
 Severe disability 23%
 Crippling disability 5%
 No data 5%
TPDT
 TPDT vertical (1–10 cm), mean (SD) 4.9 (1.6)
 TPDT horizontal (1–10 cm), mean (SD) 6.0 (1.5)
Fig. 1 Time course of the vertical TPDTs over 6 months. T1: timepoint 
1 (< 4 weeks), T2: timepoint 2 (3 months), T3: timepoint 3 (6 months). 
TPDT: Two‑point discrimination threshold measured with a plastic 
calliper ruler in vertical and horizontal direction from 1‑10 cm
Fig. 2 Time course of the horizontal TPDTs over 6 months. T1: 
timepoint 1 (< 4 weeks), T2: timepoint 2 (3 months), T3: timepoint 3 
(6 months). TPDT: Two‑point discrimination threshold measured with 
a plastic calliper ruler in vertical and horizontal direction from 1‑10 cm
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relevant time-predictor interaction effects on ODI and 
pain intensity. In the evaluations with ODI, negative 
time-predictor interaction effects were found with the 
TPDT for vertical and horizontal TPDT between both 
T1 / T2 and T1 / T3. In the evaluations with pain inten-
sity similar negative time-predictor interaction effects 
were found with the TPDT for vertical and horizontal 
TPDT but only between T1 / T2.
Discussion
Our data show horizontal TPDTs ≥ 6  cm in acute 
LBP patients and slightly decreasing TPDTs over 
6  months. Furthermore, moderate correlations were 
found between the TPDT, the ODI and pain intensity. 
Our study provides no evidence that baseline values of 
TPDTs are predictors of persistent pain or disability in 
CLBP.
TPDT in the acute pain state
While there is a well-established body of literature on 
the TPDT for healthy adults, there is no comparable 
work on the TPDT for clinical acute LBP subjects. 
Healthy volunteers without back pain showed TPDTs 
as follows: TPDT mean (SD) vertical left 4.32  cm 
(1.58), vertical right 4.33  cm (1.44), horizontal left 
4.53  cm (1.13) and horizontal right 4.46  cm (1.14) 
in 25–61-year olds [20]. Current findings show that 
TPDTs are higher in subjects with CLBP compared to 
healthy subjects [21, 22]. Our study in subjects with 
clinical acute LBP shows higher TPDTs: mean (SD) 
4.9  cm (1.6) in the vertical direction and 6.0  cm (1.5) 
in the horizontal direction. In addition, TPDT is also 
increased in experimental acute LBP with deteriora-
tion of TPDT mean (SD) from 5.7  cm (0.7) to 6.4  cm 
(0.8) shortly after pain was induced [33]. These com-
parable results support the current understanding of 
altered TPDT in an acute pain state. Thus, it is possi-
ble that TPDTs are generally elevated in subjects with 
LBP regardless of the duration of LBP. The reason for 
increased TPDT in subjects with acute experimental 
LBP was thought to be the nociceptive pain itself [33]. 
However, in other pain states it remains unclear and 
requires further investigation.
The observation of the baseline TPDTs in this study 
showed larger TPDTs in horizontal direction compared 
to vertical direction. This finding is in line with the results 
of others [20], which also found higher horizontal TPDTs 
although in healthy volunteers. Movement in the fron-
tal direction might stretch the skin in the vertical direc-
tion, thus smaller TPDT would hamper the adequate skin 
response [20].
Standardised TPDT assessment procedures do not yet 
exist. This affects the interpretation and comparability of 
study results. Amongst other reasons, the stimulus size 
has shown to be an important factor in TPDT assess-
ments [34–36].
Earlier studies reported on the use of pressure until 
the very first blanching of the skin [24, 37], whereas 
other assessment procedures use 1 mm skin pressure to 
standardise stimulus levels [38]. In addition, the TPDT 
protocol [35], measurement instruments [39] and intra-
rater capabilities [40] contribute to between and within 
subject variability. A standardised TPDT measurement 
would certainly enhance the interpretation of differ-
ent results. In addition, inherent natural variability of 
tactile acuity in subjects with LBP and healthy controls 
might contribute to the variability of TPDT. It is likely 
Fig. 3 Time course of the ODI over 6 months. T1: timepoint 
1 (< 4 weeks), T2: timepoint 2 (3 months), T3: timepoint 
3 (6 months). ODI: Oswestry Disability Index (ODI‑Index): 
Score ≤ 20% = minimal disability; Score 21‑ 40% = moderate 
disability; Score ≤ 41‑ 60% = high disability; Score 61–80% = very 
high disability; Score > 81% in need of care or psycho‑socially 
extremely overlaid (28). NRS: Numeric Rating Scale (NRS) 0–10
Fig. 4 Time course of the NRS over 6 months. T1: timepoint 
1 (< 4 weeks), T2: timepoint 2 (3 months), T3: timepoint 
3 (6 months). ODI: Oswestry Disability Index (ODI‑Index): 
Score ≤ 20% = minimal disability; Score 21‑ 40% = moderate 
disability; Score ≤ 41‑ 60% = high disability; Score 61–80% = very 
high disability; Score > 81% in need of care or psycho‑socially 
extremely overlaid [28]. NRS: Numeric Rating Scale (NRS) 0–10
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that some of these factors contributed to the variability 
observed in this study.
Time progression of the TPDT, ODI and pain intensity
Our findings show that TPDTs change only minimally 
over a period of 6 months. This indicates that the TPDTs 
remain unchanged without further treatment. Previous 
studies on subjects with CLBP have demonstrated that 
Table 2 Time progression of the variables
T1 Time point 1 (< 4 weeks), T2 Time point 2 (3 months), T3 Time point 3 (6 months), TPDT Two-point discrimination threshold measured with a plastic calliper ruler 
in vertical and horizontal direction from 1–10 cm, ODI Oswestry Disability Index score ≤ 20% = minimal disability; score 21- 40% = moderate disability; score ≤ 41- 
60% = severe disability; score 61–80% = crippling disability; score > 81% bed-bound [28], NRS Numeric Rating Scale (NRS) 0–10
T1 T2 T3
Subjects Frequency Subjects Frequency Subjects Frequency
Vertical TPDT
 ≥ 6 cm 21 20% 15 15% 15 15%
  < 6 cm 82 80% 67 65% 59 57%
 No data 0 0% 21 20% 29 28%
Horizontal TPDT
  ≥ 6 cm 59 57% 37 36% 31 30%
  < 6 cm 44 43% 45 44% 43 42%
 No data 0 0% 21 20% 29 28%
ODI
 Minimal disability 5 5% 22 21% 29 28%
 Moderate disability 64 62% 52 50% 40 39%
 Severe disability 24 23% 9 9% 6 6%
 Crippling disability 5 5% 2 2% 1 1%
 No data 5 5% 18 17% 27 26%
NRS
 NRS 0 ‑ ‑ 46 45% 43 42%
 NRS 1–3 66 64% 27 26% 23 22%
 NRS ≥4 35 34% 9 9% 9 9%
 No data 2 2% 21 20% 28 27%
Table 3 Spearman Rank Correlations of TPDT and ODI/NRS
N Number of subjects, R Spearman Rank Correlation, 95%CI 95% confidence 
interval, NRS Numeric Rating Scale (NRS) 0–10, ODI Oswestry Disability Index 
score 0–100%, TPDT Two-point discrimination threshold in vertical and 
horizontal direction from 1–10 cm
N R 95% CI
TPDT vertical / ODI
 T1 98 0.12 –0.08 to 0.31
 T2 82 –0.05 –0.25 to 0.16
 T3 74 0.33 0.12 to 0.53
TPDT vertical / NRS
 T1 101 –0.06 –0.25 to 0.14
 T2 82 0.06 –0.17 to 0.26
 T3 74 0.25 0.01 to 0.46
TPDT horizontal / ODI
 T1 98 0.15 –0.08 to 0.35
 T2 82 0.27 0.03 to 0.49
 T3 74 0.38 0.15 to 0.58
TPDT horizontal / NRS
 T1 101 0.03 –0.17 to 0.23
 T2 82 –0.14 –0.35 to 0.06
 T3 74 –0.03 –0.26 to 0.21
Table 4 Linear mixed model for ODI with vertical TPDT as 
predictor
TPDT Two-point discrimination threshold, ODI Oswestry Disability Index, T1 Time 
point 1 (< 4 weeks), T2 Time point 2 (3 months), T3 Time point 3 (6 months), 
Vertical TPDT T1xT2 and Vertical TPDT T1xT3 Interaction effects of TPDT and 
time on ODI, Estimate Estimated fixed effects, SE Standard Error, 95% CI 95% 
confidence interval of estimated effect
Parameter Estimate SE 95% CI
Intercept, β0 29.47 4.18 21.34 to 37.59
Vertical TPDT, β2 –0.44 0.67 –1.73 to 0.86
T2, β1,1 –2.95 3.46 –9.74 to 3.77
T3, β1,2 –5.20 3.61 –12.32 to 1.80
Age, C 0.23 0.08 0.09 to 0.38
Vertical TPDT x T2, β3,1 –0.86 0.66 –2.15 to 0.44
Vertical TPDT x T3, β3,2 –0.83 0.69 –2.18 to 0.53
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sensory discrimination training can improve pain and 
function [41]. Thirty minutes of tactile acuity training 
for CLBP subjects is sufficient to achieve an improve-
ment in the TPDT [42]. However, whether subjects with 
acute LBP would also benefit from tactile acuity training 
remains unclear. Given the fact that chronic and acute 
LBP revealed similar TPDTs, tactile acuity training might 
work in a similar way.
In terms of disability, this study shows a substantial 
decrease for the ODI index over 6  months, as shown 
previously.
Regarding pain, the study findings demonstrate a 
steep decrease in the pain intensity, especially within 
the first 3  months and a lower decrease of the NRS 
value after 6  months. Similar observations have been 
reported previously investigated in acute LBP up to 3 
and 6 months [43].
Some 35% of the test persons in the study still suf-
fered from pain after 3 months, with the rate remaining 
at about 31% at the end of the 6  months. By definition, 
about one third of the subjects therefore suffered from 
chronic pain, since a patient is considered cured only 
when the cut-off NRS 0/10 is not exceeded [44].
However, one should be careful to assume that the pro-
gression of pain and disability over 3 and 6 months is the 
same for each person. From other studies, we are aware 
that the progression for an individual subject can be com-
pletely different from the mean group progression [45]. 
Furthermore, LBP is not a condition in which rapid recov-
ery is experienced or chronic severe pain developed. In 
contrast, LBP might be interpreted as a state of persistent 
or fluctuating pain of low or moderate intensity [46].
Prediction of pain and disability
The regression analysis showed no predictive value of the 
TPDT for disability or pain at 3 and 6 months after pain 
onset. To the best of our knowledge, this is a novel find-
ing and has not been demonstrated so far.
The results of the regression analysis with the ODI 
were puzzling. The correlation between the ODI and 
the TPDT was negative at all time points (T1-T3). In the 
evaluations with pain intensity, similar negative interac-
tion effects were found with the TPDT at T2. Moder-
ate correlations were found between the TPDT and the 
ODI after 6  months. There were only weak correlations 
between the TPDT and the pain intensity. These results 
agree with findings from other studies, demonstrating 
that tactile acuity deficits may be independent of the per-
ceived intensity of pain [22].
The overall large confidence intervals of the estimated 
effects demonstrate the difficulty in generalising our results 
and shows that there is a wide spread of values and thus the 
conclusion of the correlations become more uncertain.
Table 5 Linear mixed model for ODI with horizontal TPDT as 
predictor
TPDT Two-point discrimination threshold, ODI Oswestry Disability Index, T1 Time 
point 1 (< 4 weeks), T2 Time point 2 (3 months), T3 Time point 3 (6 months), 
Horizontal TPDT T1xT2 and Horizontal TPDT T1xT3 Interaction effects of TPDT and 
time on ODI, Estimate Estimated fixed effects, SE Standard Error, 95% CI 95% 
confidence interval of estimated effect
Parameter Estimate SE 95% CI
Intercept, β0 28.50 4.68 19.41 to 37.59
Horizontal TPDT, β2 –0.14 0.70 –1.50 to 1.22
T2, β1,1 –1.89 4.27 –10.20 to 6.43
T3, β1,2 –5.78 4.44 –14.46 to 2.86
Age, C 0.23 0.08 0.08 to 0.37
Horizontal TPDT x T2, β3,1 –0.90 0.69 –2.25 to 0.45
Horizontal TPDT x T3, β3,2 –0.60 0.73 –2.02 to 0.81
Table 6 Linear mixed model for NRS with vertical TPDT as 
predictor
TPDT Two-point discrimination threshold, NRS Numeric Rating Scale, T1 Time 
point 1 (< 4 weeks), T2 Time point 2 (3 months), T3 Time point 3 (6 months), 
Vertical TPDT T1xT2 and Vertical TPDT T1xT3 Interaction effects of TPDT and 
time on NRS, Estimate Estimated fixed effects, SE Standard Error, 95% CI 95% 
confidence interval of estimated effect
Parameter Estimate SE 95% CI
Intercept, β0 1.97 0.69 0.62 to 3.31
Vertical TPDT, β2 –0.08 0.12 –0.30 to 0.15
T2, β1,1 –0.88 0.77 –2.38 to 0.61
T3, β1,2 –1.59 0.78 –3.11 to –0.08
Age, C 0.02 0.01 –0.00 to 0.04
Vertical TPDT x T2, β3,1 –0.08 0.15 –0.36 to 0.21
Vertical TPDT x T3, β3,2 0.04 0.15 –0.25 to 0.32
Table 7 Linear mixed model for NRS with horizontal TPDT as 
predictor
TPDT Two-point discrimination threshold, NRS Numeric Rating Scale, T1 Time 
point 1 (< 4 weeks), T2 Time point 2 (3 months), T3 Time point 3 (6 months), 
Horizontal TPDT T1xT2 and Horizontal TPDT T1xT3 Interaction effects of TPDT and 
time on NRS, Estimate Estimated fixed effects, SE Standard Error, 95% CI 95% 
confidence interval of estimated effect
Parameter Estimate SE 95% CI
Intercept, β0 1.58 0.79 0.05 to 3.12
Horizontal TPDT, β2 0.03 0.12 –0.21 to 0.26
T2, β1,1 –1.02 0.95 –2.87 to 0.82
T3, β1,2 –1.85 1.00 –3.81 to 0.10
Age, C 0.02 0.01 0.0 to 0.04
Horizontal TPDT x T2, β3,1 –0.04 0.15 –0.34 to 0.26
Horizontal TPDT x T3, β3,2 0.07 0.16 –0.25 to 0.39
Page 8 of 9Morf et al. BMC Musculoskelet Disord          (2021) 22:666 
It may be concluded that TPDT, NRS and ODI values 
do not behave similarly because they measure different 
constructs. While the TPDT is a measurement of skin 
perception, the NRS measures pain intensity as a sub-
jective sensory experience and the ODI index assesses 
patient subjective abilities in daily tasks. A comparison of 
these measures may therefore not be meaningful.
Strengths and limitations
This study is the first prospective longitudinal study to 
investigate the ability of the TPDT to predict pain and 
disability. The high dropout rate of 16.9% over the period 
of 6 months led to a certain loss of data and must be con-
sidered when interpreting the results. Furthermore, this 
study was embedded in a larger project, in which a huge 
amount of additional data was collected. Adherence to 
the defined examination dates also led to a high burden 
on the test subjects.
The generalisability of the results is weakened by the 
lack of a representative population sampling. Due to the 
localisation of recruitment, many young and well-edu-
cated subjects were included. Additionally, the TPDT 
measurement could not always be performed by the same 
test person, due to the large number of assessors and to 
the fact that they were part-time students. Furthermore, 
the absence of repeated measurements at baseline must 
be considered as a potential confounder for the interpre-
tation of the results.
More baseline data regarding "chronicity risk" would 
have allowed for more complex ways of looking at the 
process. Stratification of participants according to their 
risk of future disability would have been useful to identify 
participants most likely to be affected by a future decline 
in tactile acuity [47].
Conclusion
This study investigated the ability of TPDTs to predict 
pain and disability in acute LBP subjects over a period 
of 6 months, using measurements of vertical and hori-
zontal TPDTs at 3 and 6  months. The study demon-
strated elevated TPDTs in acute LBP persons and only 
minimal changes in TPDTs over the 6-month period. 
The results indicate that TPDT has no predictive value 
for disability and pain at 3 and 6  months after pain 
onset. Therefore, further research is needed to clarify 
the effects and therapeutic value of TPDT in acute 
LPB.
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